Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations

Conditions:   Renal Cell Carcinoma;   Metastatic Renal Cell Carcinoma;   Kidney Cancer;   Renal Carcinoma;   Kidney Cancer Metastatic Intervention:   Drug: Olaparib Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials